Akademik Veri Yönetim Sistemi
Journal of Evaluation in Clinical Practice, 2024 (SCI-Expanded)
Background and Aim: Urinary incontinence is an important problem with potentially adverse effects on the psychological, social and personality development of children. Today, with the developing technology, the use of information and communication technologies such as wearable technology, message services and mobile applications has become widespread in solving health problems. In this study, it was aimed to develop a mobile application that facilitates the follow-up of children, increases their compliance with treatment and ensures the continuity of communication between them and the health worker. The methodology, design and preliminary evaluation results of the mobile application are presented in this article. Methods: During the development process of the mobile application, the content was first created in line with the literature review. After the content was determined, the interface design was made on MS Word and Photoshop software. At this stage, six experts were consulted for content and design. The mobile application, finalised in design, was implemented on Android and IOS platforms. After the mobile application was created, 10 children and their families were interviewed. Results: Nine of the families (90%) found the developed mobile application useful and easy to use. Families' suggestions to improve the mobile application were to make it more interesting for children and to enrich its content. Conclusion: In line with the feedback, the mobile application was updated and finalised. Preliminary results are promising that the developed mobile application can be used as an aid to treatment in children with urinary incontinence. With the mobile application developed, urotherapy training was not limited to the time they visited the hospital. This suggests that the mobile application can eliminate the problem of partial or omitted treatment. This research has shown that leveraging technology can be a good option to increase treatment success. Clinical Trial Number: NCT05815940.